Form 4/A for LUNG Pulmonx Corp
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-007232 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2024-03-07 | 2024-03-01 | LUNG | McKune John | INTERIM CFO | A - Grant | $0.00 | +28.8K | 76.2K | +61% | $0 |
| DA | 2024-03-07 | 2024-03-01 | LUNG | McKune John | INTERIM CFO | A - Grant | $0.00 | +14.4K | 14.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 28,800 | $0.00 | 76,210 | D | — | — | (F1) Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-03-01 | A | A | 14,400 | $0.00 | 14,400 | D | $9.30 · — to 2034-02-28 | 14,400 Common Stock | (F2) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. |